Back
Amicus Therapeutics Stock Price Chart
Sell
32
FOLD
Amicus Therapeutics
Last Price:
9.50
Seasonality Move:
24.43%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing slight buying pressure.
Amicus Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.6 | Sell |
| 20-day SMA: | 10.09 | Sell |
| 50-day SMA: | 10.93 | Sell |
| 200-day SMA: | 11.96 | Sell |
| 8-day EMA: | 9.62 | Sell |
| 20-day EMA: | 10.04 | Sell |
| 50-day EMA: | 10.82 | Sell |
| 200-day EMA: | 11.75 | Sell |
Amicus Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.46 | Sell |
| Relative Strength Index (14 RSI): | 36.72 | Sell |
| Chaikin Money Flow: | 612451 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.68 - 10.68) | Sell |
| Bollinger Bands (100): | (10.72 - 13.46) | Sell |
Amicus Therapeutics Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Amicus Therapeutics Stock
Is Amicus Therapeutics Stock a Buy?
- Amicus Therapeutics share price is 9.50 while FOLD 8-day simple moving average is 9.60, which is a Sell signal.
- The stock price of FOLD is 9.50 while Amicus Therapeutics 20-day SMA is 10.09, which makes it a Sell.
- Amicus Therapeutics 50-day simple moving average is 10.93 while FOLD share price is 9.50, making it a Sell technically.
- FOLD stock price is 9.50 and Amicus Therapeutics 200-day simple moving average is 11.96, creating a Sell signal.
FOLD Technical Analysis vs Fundamental Analysis
Sell
32
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy or a Sell?
-
Amicus Therapeutics stock is rated a Sell
The current Amicus Therapeutics [FOLD] share price is $9.50. The Score for FOLD is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Amicus Therapeutics Stock Info
Market Cap:
2.81B
Price in USD:
9.50
Share Volume:
2.38M
Amicus Therapeutics 52-Week Range
52-Week High:
14.57
52-Week Low:
9.02
Sell
32
Amicus Therapeutics (FOLD)
is a Sell
Amicus Therapeutics Share Price Forecast
-
What is the Amicus Therapeutics stock price today?
The Amicus Therapeutics stock price is 9.50 USD today. -
Will FOLD stock go up or go down?
Amicus Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Amicus Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amicus Therapeutics is overvalued.
Is Amicus Therapeutics Stock a Buy?
- Amicus Therapeutics share price is 9.50 while FOLD 8-day exponential moving average is 9.62, which is a Sell signal.
- The stock price of FOLD is 9.50 while Amicus Therapeutics 20-day EMA is 10.04, which makes it a Sell.
- Amicus Therapeutics 50-day exponential moving average is 10.82 while FOLD share price is 9.50, making it a Sell technically.
- FOLD stock price is 9.50 and Amicus Therapeutics 200-day simple moving average is 11.75, creating a Sell signal.
Fundamental Analysis of Amicus Therapeutics
Is Amicus Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.03 per share, an increase this year of $0.50 per share, and an increase next year of $0.40 per share.
Technical Analysis of Amicus Therapeutics
Should I short Amicus Therapeutics stock?
- FOLD Moving Average Covergence Divergence (MACD) indicator is -0.46, suggesting Amicus Therapeutics is a Sell
- Amicus Therapeutics Relative Strength Index (RSI) is 36.72, which suggest Amicus Therapeutics is oversold
- The Bollinger Bands (25) for Amicus Therapeutics is (9.68 - 10.68), which suggest Amicus Therapeutics is a Sell
- The Bollinger Bands (100) for Amicus Therapeutics is (10.72 - 13.46), which suggest Amicus Therapeutics is a Sell
* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.